United Community Bank Ionis Pharmaceuticals Inc Transaction History

United Community Bank

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Feb 13, 2024	SELL	$34.73 - $43.33 $39,279 - $49,006	-1,131 Closed	0 $0
Q4 2022 Feb 13, 2024	BUY	$37.12 - $46.52 $185 - $232	5 Added 0.44%	1,131 $42.7 Million
Q3 2022 Feb 13, 2024	BUY	$36.54 - $48.66 $2,923 - $3,892	80 Added 7.65%	1,126 $49.8 Million
Q2 2022 Feb 13, 2024	BUY	$31.71 - $43.0 $2,505 - $3,397	79 Added 8.17%	1,046 $38.7 Million
Q1 2022 Feb 13, 2024	BUY	$29.88 - $37.04 $149 - $185	5 Added 0.52%	967 $35.8 Million
Q4 2021 Feb 13, 2024	BUY	$25.61 - $35.1 $24,636 - $33,766	962 New	962 $29.3 Million

404

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.07B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of United Community Bank, based on Form 13F filings with the SEC.

Stay updated on United Community Bank with notifications on news.